Methyl Aminolevulinate

CHEMBL1096562 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
145.2 g/mol
LogP
-1.0
Phase
4

A photosensitizer for photodynamic therapy of actinic keratoses.

分子量

145.1600 g/mol

LogP

-1.00

TPSA

69.40 Ų

リピンスキーの五則

適合

治療領域

作用機序

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COC(=O)CCC(=O)CN

InChI

InChI=1S/C6H11NO3/c1-10-6(9)3-2-5(8)4-7/h2-4,7H2,1H3

Molecular Formula

C6H11NO3

HBD / HBA

1 / 4

回転可能結合数

5

重原子数

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A photosensitizer for photodynamic therapy of actinic keratoses.

Accumulates in target tissues and generates reactive oxygen species upon activation by specific wavelengths of light, causing localized cellular damage and destruction of pathological tissue.

Yes, Methyl Aminolevulinate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1096562. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 157922. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.